Table 3 Comparison of the pathological and postoperative characteristics of good responders and poor responders
Good responders (N = 47) | Poor responders (N = 55) | p | |
|---|---|---|---|
ypT stage, N (%) | |||
T0–2 | 25 (53.2) | 14 (25.5) | 0.004 |
T3 and T4 | 22 (46.8) | 41 (74.5) | |
ypN stage, N (%) | |||
Negative | 32 (68.1) | 32 (58.2) | 0.30 |
Positive | 15 (31.9) | 23 (41.8) | |
Pathological LPLN, N (%) | |||
Negative | 40 (85.1) | 43 (78.2) | 0.37 |
Positive | 7 (14.9) | 12 (21.8) | |
Histological type, N (%) | |||
Well and moderately differentiated | 45 (95.7) | 51 (92.7) | 0.42 |
Poorly differentiated | 2 (4.3) | 4 (7.3) | |
Pathological CRM, N (%) | |||
Negative | 42 (89.4) | 48 (87.3) | 0.74 |
Positive | 5 (10.6) | 7 (12.7) | |
Distal margin, N (%) | |||
Negative | 47 (100.0) | 54 (98.2) | 0.54 |
Positive | 0 (0.0) | 1 (1.8) | |
Adjuvant chemotherapy, N (%) | |||
Absence | 3 (6.4) | 6 (10.9) | 0.33 |
Presence | 44 (93.6) | 49 (89.1) | |